A new strategy for tuberculosis (TB) screening, proposed by a team of researchers led by Queen Mary University of London, ...

An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, investigators ...

An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, Johns Hopkins ...

An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, Johns Hopkins ...

TB Alliance's third licensed manufacturer makes pretomanid available through the Global Drug Facility, further improving affordability and accessTB Alliance applauds a new milestone in the fight ...

In a Johns Hopkins Children’s Center study, the addition of navitoclax to the standard TB treatment significantly increased apoptosis (shown in red) in several lung cell populations including ...

In a lab in the heart of Boston, professor Bree Aldridge leads a team of researchers trying to understand a threat that is ...

“Through close collaboration with manufacturers, we have addressed critical unmet needs by developing practical solutions that make available and effective drug-resistant TB treatments not only ...

SHAH ALAM: The Selangor government will continue the RM800 Tuberculosis (TB) Treatment Incentive this year. State Public Health and Environment Committee chairman Jamaliah Jamaluddin said the ...

Our interpretation of the themes across all studies produced a line-of-argument synthesis describing how four major factors interact to affect adherence to TB treatment: structural factors ...